Vallée, T. C. Et Al. 2024. Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival. Blood , vol.143, no.24 , 2504-2516.

Vallée, T. C., Glasmacher, J. S., Buchner, H., Arkwright, P. D., Behrends, U., Bondarenko, A., ... Browning, M. J.(2024). Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival. Blood , vol.143, no.24, 2504-2516.

Vallée, Tanja Et Al. "Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival," Blood , vol.143, no.24, 2504-2516, 2024

Vallée, Tanja C. Et Al. "Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival." Blood , vol.143, no.24, pp.2504-2516, 2024

Vallée, T. C. Et Al. (2024) . "Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival." Blood , vol.143, no.24, pp.2504-2516.

@article{article, author={Tanja C. Vallée Et Al. }, title={Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival}, journal={Blood}, year=2024, pages={2504-2516} }